Mirae Asset Global Investments Co. Ltd. Reduces Stock Holdings in HealthEquity, Inc. $HQY

Mirae Asset Global Investments Co. Ltd. decreased its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 98.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 279 shares of the company’s stock after selling 24,376 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in HealthEquity were worth $29,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HQY. GAMMA Investing LLC lifted its position in HealthEquity by 25.9% during the first quarter. GAMMA Investing LLC now owns 1,571 shares of the company’s stock valued at $139,000 after buying an additional 323 shares during the period. SG Americas Securities LLC lifted its position in HealthEquity by 7.1% during the first quarter. SG Americas Securities LLC now owns 5,843 shares of the company’s stock valued at $516,000 after buying an additional 388 shares during the period. Integrated Advisors Network LLC purchased a new position in HealthEquity during the first quarter valued at $259,000. Fifth Third Bancorp lifted its position in HealthEquity by 17.5% during the first quarter. Fifth Third Bancorp now owns 955 shares of the company’s stock valued at $84,000 after buying an additional 142 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its position in HealthEquity by 24.7% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company’s stock valued at $564,000 after buying an additional 1,265 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on HQY. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. Jefferies Financial Group lifted their price target on HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, September 3rd. KeyCorp lowered their price target on HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a research report on Wednesday. JPMorgan Chase & Co. lifted their price target on HealthEquity from $125.00 to $126.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 3rd. Finally, Royal Bank Of Canada lifted their price target on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $121.31.

Insider Activity

In other HealthEquity news, EVP Delano Ladd sold 6,000 shares of the business’s stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the sale, the executive vice president directly owned 79,456 shares in the company, valued at $7,477,604.16. The trade was a 7.02% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. This represents a 3.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by company insiders.

HealthEquity Price Performance

NASDAQ HQY opened at $90.54 on Monday. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65. The stock has a 50-day moving average of $91.62 and a 200 day moving average of $93.90. The company has a market capitalization of $7.80 billion, a price-to-earnings ratio of 54.87, a PEG ratio of 1.30 and a beta of 0.47. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%.The company had revenue of $325.80 million during the quarter, compared to the consensus estimate of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. On average, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.